- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 59/245 - Saturated compounds having more than one carboxyl group containing hydroxy or O-metal groups
Patent holdings for IPC class C07C 59/245
Total number of patents in this class: 131
10-year publication summary
7
|
14
|
14
|
10
|
13
|
14
|
4
|
18
|
8
|
9
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novartis AG | 10883 |
5 |
Mitsubishi Chemical Corporation | 4492 |
4 |
Takeda Pharmaceutical Company Limited | 2708 |
4 |
Synthon BV | 311 |
4 |
R.J. Reynolds Tobacco Company | 503 |
3 |
Merck Sharp & Dohme LLC | 3743 |
3 |
Mitsubishi Rayon Co., Ltd. | 918 |
2 |
Actavis Group PTC ehf | 474 |
2 |
Apotex Inc. | 202 |
2 |
Archer Daniels Midland Company | 1111 |
2 |
Balchem Corporation | 78 |
2 |
ChemTreat, Inc. | 224 |
2 |
Cyclacel Limited | 64 |
2 |
Dr. Reddy's Laboratories Limited | 558 |
2 |
Esperion Therapeutics, Inc. | 67 |
2 |
Exelixis, Inc. | 406 |
2 |
Furman University | 39 |
2 |
Genzyme Corporation | 1238 |
2 |
Glykon Technologies Group, LLC | 16 |
2 |
JEFO Nutrition Inc. | 75 |
2 |
Other owners | 80 |